GSK on Monday said that the European Medicines Agency has agreed to review a request to approve the British drugmaker's asthama drug Nucala as an additional treatment for chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype.

image for news GSK says European regulator reviewing expanded use of asthma drug Nucala

SoFi Technologies Shows Great Potential Despite Recession Fears — Neutral

SOFI   Seeking Alpha — March 24, 2025

SoFi Technologies stock has seen a correction of 30% since the recent earnings in which it was able to beat the estimates. The correction seems to be overdone as the fundamental numbers of the company are quite strong with 34% YoY growth in members and 26% YoY growth in adjusted revenue. The company is moving away from lending products, which can be seen by the higher mix of financial services products.

image for news SoFi Technologies Shows Great Potential Despite Recession Fears

UK's Argo Blockchain names Justin Nolan CEO — Neutral

ARBK  ARBKF   Reuters — March 24, 2025

British cryptocurrency miner Argo Blockchain on Monday named Justin Nolan as its chief executive officer.

image for news UK's Argo Blockchain names Justin Nolan CEO

Gold prices hover near $3,025 as traders eye U.S. inflation data and trade policy for direction. Rate cut bets and geopolitical risks support demand.

image for news Gold (XAU) Silver (XAG) Daily Forecast: $3,025 Pivot in Focus as Inflation and Tariff News Loom

Peloton stock price has crashed: buy the dip or sell the rip? — Negative

PTON   Invezz — March 24, 2025

Peloton stock price has suffered a harsh reversal in the past few months as concerns about its growth continued. PTON was trading at $6.95 on Friday, down by 36% from its highest level in January last year.

image for news Peloton stock price has crashed: buy the dip or sell the rip?

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your Alarum Technologies Ltd. (NASDAQ:ALAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alarum-technologies-ltd-lawsuit-submission-form?prid=138166&wire=1 or contact Joseph E.

image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in Alarum Technologies Ltd. Lawsuit - ALAR

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=138167&wire=1 or contact Joseph E. Levi, Esq.

image for news April 15, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against TMDX

Canadian Solar Inc. CSIQ will release its first-quarter financial results, before the opening bell, on Tuesday, March 25.

image for news Canadian Solar Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Transaction in Own Shares — Neutral

DEC   GlobeNewsWire — March 24, 2025

Diversified Energy Company PLC (LSE: DEC) (NYSE: DEC) announces that, in accordance with the terms of its share buyback program announced on 20 March 2025, the Company has purchased 12,000 Ordinary Shares of 20p each in the capital of the Company (the "Shares") in the market at a volume weighted average price of 1,043.48p per Share through Peel Hunt LLP ("Peel Hunt"). The Shares acquired will, in due course, be cancelled.

image for news Transaction in Own Shares

Caledonia approves quarterly dividend — Neutral

CMCL   GlobeNewsWire — March 24, 2025

ST HELIER, Jersey, March 24, 2025 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) is pleased to announce that the board of directors has approved a quarterly dividend of 14 United States cents (US$0.14) on each of the Company's shares.

image for news Caledonia approves quarterly dividend

Argo Blockchain PLC Announces Appointment of Chief Executive Officer — Neutral

ARBK   Accesswire — March 24, 2025

Appointment of Chief Executive Officer and PDMR Notification LONDON, UNITED KINGDOM / ACCESS Newswire / March 24, 2025 / Argo Blockchain plc, (LSE:ARB)(NASDAQ:ARBK), is pleased to announce that it has appointed Justin Nolan as Chief Executive Officer and Director with effect as of 22 March 2025. Justin Nolan most recently was Chief Executive Officer at Arkon Energy, a digital infrastructure company.

image for news Argo Blockchain PLC Announces Appointment of Chief Executive Officer

Apple announces $99 million new clean energy fund in China — Positive

AAPL   Reuters — March 24, 2025

Apple Inc said on Monday it will set up a new clean energy fund in China worth 720 million yuan ($99.22 million), coinciding with a Beijing visit of its CEO Tim Cook.

image for news Apple announces $99 million new clean energy fund in China

Higher High, Lower High; AMD Is A Buy — Positive

AMD   Seeking Alpha — March 24, 2025

AMD's growth momentum is strong, with an expectation for the current trend to continue for the foreseeable future. Yet, due to the macroeconomic factors, the investor sentiment surrounding AMD has soured leading to a valuation multiple contraction. When investor sentiment returns, AMD will see valuation multiple expansion from a higher base or a higher EPS as a result of a continued growth.

image for news Higher High, Lower High; AMD Is A Buy

Natural gas breaks below triangle support as bearish pressure mounts; meanwhile, oil holds steady above key EMAs, signaling possible bullish momentum.

image for news Natural Gas and Oil Forecast: Triangle Breakdown in NG, Oil Holds Above Key EMAs

The open-source shift has been spearheaded by AI startup DeepSeek, whose R1 model released earlier this year challenged American tech dominance. Chinese AI companies from big players such as Baidu to smaller ones such as ManusAI have been increasingly endorsing open-source licensing models.

image for news China's open-source embrace upends conventional wisdom around artificial intelligence

Novo Nordisk's latest trial results for its next-generation obesity drug CagriSema disappointed investors by failing to show superior outcomes to existing drugs. CagriSema, which includes a nascent form of weight loss treatment known as an amylin analog, is one of the Danish pharma's next bets on the burgeoning obesity market.

image for news Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure

Châtillon, France, March 24, 2025 DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for Biologics License Application (BLA) for Viaskin® Peanut Patch in 4 – 7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, and Reports 2024 Unaudited Financial Results 1 COMFORT Children supplemental safety study in children 4 – 7-years-old no longer required FDA confirms safety exposure data generated from VITESSE Phase 3 clinical study and VITESSE Open-Label Extension (OLE) are sufficient to support a Biologics License Application (BLA) for Viaskin peanut patch in children 4 – 7-years-old VITESSE topline results on-track for …

image for news DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results

Press Release: Availability of the Q1 2025 Aide mémoire — Neutral

SNY   GlobeNewsWire — March 24, 2025

Availability of the Q1 2025 Aide mémoire Paris, France – March 24, 2025. Sanofi announced today that its Q1 2025 Aide mémoire is available on the "Investors" page of the company's website: First quarter 2025 (sanofi.com) As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results.

image for news Press Release: Availability of the Q1 2025 Aide mémoire

Tesla: Beaten Down, Out-Of-Favor And A Strong Buy — Positive

TSLA   Seeking Alpha — March 24, 2025

Tesla's stock has dropped 40% YTD due to political controversies, Cybertruck issues, and market maturation, but these are seen as short-term negatives. Despite recent setbacks, Tesla's long-term growth potential remains strong, supported by its leading position in the U.S. EV market and robust delivery volumes. Temporary factors like consumer boycotts and tariffs are expected to fade, offering a significant re-rating opportunity and potential alpha for investors.

image for news Tesla: Beaten Down, Out-Of-Favor And A Strong Buy

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your e.l.f. Beauty, Inc. (NYSE:ELF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/e-l-f-beauty-lawsuit-submission-form?prid=138164&wire=1 or contact Joseph E.

image for news Levi & Korsinsky Reminds e.l.f. Beauty, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - ELF